selected publications
- A Vesiculopustular Skin Eruption. Rhode Island medical journal (2013). 2026 Academic Article GET IT
- Monoclonal Cryoglobulinemia Clinically Mimicking Leukocytoclastic Vasculitis: A Case Report and Literature Review. The American Journal of dermatopathology. 2025 Review GET IT
-
Cytophagic histiocytic panniculitis leading to a diagnosis of acute myeloid leukemia with monocytic differentiation: A case report and literature review.
Journal of cutaneous pathology.
2024
Review
GET IT
Times cited: 1 -
The role of p53 in anti-tumor immunity and response to immunotherapy.
Frontiers in molecular biosciences.
2023
Review
GET IT
Times cited: 24 -
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2023
Academic Article
GET IT
Times cited: 9 -
Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer.
Cancer research.
2023
Academic Article
GET IT
Times cited: 21 - MDM2/MDM4 amplification and CDKN2A deletion in metastatic melanoma and glioblastoma multiforme may have implications for targeted therapeutics and immunotherapy. American journal of cancer research. 2022 Academic Article GET IT
-
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies.
eLife.
2022
Academic Article
GET IT
Times cited: 23 - CDKN1A/p21WAF1, RB1, ARID1A, FLG, and HRNR mutation patterns provide insights into urinary tract environmental exposure carcinogenesis and potential treatment strategies. American journal of cancer research. 2021 Academic Article GET IT
-
Biologically informed deep neural network for prostate cancer discovery.
Nature.
2021
Academic Article
GET IT
Times cited: 296 -
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization.
Cell reports.
2021
Academic Article
GET IT
Times cited: 30 -
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Nature communications.
2021
Academic Article
GET IT
Times cited: 112 -
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 19 -
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors.
Cancer research.
2019
Academic Article
GET IT
Times cited: 54 -
Overexpression of Arabidopsis NIMIN1 results in salicylate intolerance.
Plant signaling & behavior.
2016
Academic Article
GET IT
Times cited: 8